New report now available: HCV Drugs and Vaccines Development Status – 2017
07 February 2017
Antiviral InteliStrat Inc. is preparing for scientists and decision makers a unique, exhaustive review of the HCV research and development field as it is in early 2017. See Table of Contents ("NEWS" Tab)
The Challenges of Poliovirus Eradication, by J.Yelle
12 January 2017
Following the successful efforts to wipe out the virus of Smallpox (Variola virus) that started in the 1950s and officially realized their goal in 19803, the World Health Organization (WHO) made a commitment in 1988 to eradicate Poliovirus and poliomyelitis and achieve a Polio-free world by 2000. This ambitious project proved to be much more challenging than initially anticipated.
See complete publication in "NEWS" section (Tab)
The Urgent Need for Broad-Spectrum Antiviral Drugs, by J. Yelle
18 March 2015
Antiviral Database (VIROPENDIUM)
Antiviral InteliStrat has assembled the most complete and detailed Database currently available on antiviral drugs and vaccines. This Database, called VIROPENDIUM, is accessible by subscribing through one of the following options: Custom Access, Full Access and Viral Family Access.
Note that Full Access and Viral Family Access subscription types are done on a one-year basis and that all indicated amounts are in US $ (prices include applicable taxes).
SEE BELOW for Database subscription rates and fees. Prices subject to changes without prior notice. REFUND POLICY
Antiviral InteliStrat also offers the following services:
Advertisement on Antiviral InteliStrat web site and database for sponsors seeking partnership (limited to Viral Family Access and Full Access subscribers)
Evaluation of technologies related to vaccine or antiviral drug development in the biotech and pharmaceutical industries
The cost of these particular services is variable and depends on the nature of the advertisement or the type of evaluation to be conducted. Please contact Antiviral InteliStrat to inquire about these services and their cost.